1.

Data_Sheet_1_To What Extent Do Successive Cohorts Adopt Different Publication Patterns? Peer Review, Language Use, and Publication Types in the Social Sciences and Humanities.docx

2.

Data_Sheet_1_To What Extent Do Successive Cohorts Adopt Different Publication Patterns? Peer Review, Language Use, and Publication Types in the Social Sciences and Humanities.docx

3.

Data_Sheet_1_To What Extent Do Successive Cohorts Adopt Different Publication Patterns? Peer Review, Language Use, and Publication Types in the Social Sciences and Humanities.docx

4.

Data_Sheet_1_To What Extent Do Successive Cohorts Adopt Different Publication Patterns? Peer Review, Language Use, and Publication Types in the Social Sciences and Humanities.docx

5.

Data_Sheet_1_To What Extent Do Successive Cohorts Adopt Different Publication Patterns? Peer Review, Language Use, and Publication Types in the Social Sciences and Humanities.docx

6.

Data_Sheet_1_To What Extent Do Successive Cohorts Adopt Different Publication Patterns? Peer Review, Language Use, and Publication Types in the Social Sciences and Humanities.docx

7.

Data_Sheet_1_To What Extent Do Successive Cohorts Adopt Different Publication Patterns? Peer Review, Language Use, and Publication Types in the Social Sciences and Humanities.docx

8.

Data_Sheet_1_To What Extent Do Successive Cohorts Adopt Different Publication Patterns? Peer Review, Language Use, and Publication Types in the Social Sciences and Humanities.docx

9.

Data_Sheet_1_To What Extent Do Successive Cohorts Adopt Different Publication Patterns? Peer Review, Language Use, and Publication Types in the Social Sciences and Humanities.docx

1.

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

2.

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

3.

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

4.

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

1.

Comparison of dosing algorithms for acenocoumarol and phenprocoumon using clinical factors with the standard care in the Netherlands

2.

Comparison of dosing algorithms for acenocoumarol and phenprocoumon using clinical factors with the standard care in the Netherlands

3.

Comparison of dosing algorithms for acenocoumarol and phenprocoumon using clinical factors with the standard care in the Netherlands

4.

Comparison of dosing algorithms for acenocoumarol and phenprocoumon using clinical factors with the standard care in the Netherlands

1.

Distribution of echocardiographic parameters and their associations with cardiovascular risk factors in the Rotterdam Study

2.

Distribution of echocardiographic parameters and their associations with cardiovascular risk factors in the Rotterdam Study

3.

Distribution of echocardiographic parameters and their associations with cardiovascular risk factors in the Rotterdam Study

4.

Distribution of echocardiographic parameters and their associations with cardiovascular risk factors in the Rotterdam Study

1.

A four-kallikrein panel for the prediction of repeat prostate biopsy: Data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands

2.

A four-kallikrein panel for the prediction of repeat prostate biopsy: Data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands

3.

A four-kallikrein panel for the prediction of repeat prostate biopsy: Data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands

4.

A four-kallikrein panel for the prediction of repeat prostate biopsy: Data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands

1.

Puzzling Findings in Studying the Outcome of "Real World" Adolescent Mental Health Services: The TRAILS Study

2.

Puzzling Findings in Studying the Outcome of "Real World" Adolescent Mental Health Services: The TRAILS Study

3.

Puzzling Findings in Studying the Outcome of "Real World" Adolescent Mental Health Services: The TRAILS Study

4.

Puzzling Findings in Studying the Outcome of "Real World" Adolescent Mental Health Services: The TRAILS Study

1.

Predictors of non-adherence to and non-persistence with statin therapy among patients on oral diabetes medication in the netherlands: A retrospective inception cohort study

2.

Predictors of non-adherence to and non-persistence with statin therapy among patients on oral diabetes medication in the netherlands: A retrospective inception cohort study

3.

Predictors of non-adherence to and non-persistence with statin therapy among patients on oral diabetes medication in the netherlands: A retrospective inception cohort study

4.

Predictors of non-adherence to and non-persistence with statin therapy among patients on oral diabetes medication in the netherlands: A retrospective inception cohort study

1.

A novel foil flip-over system as the final layer in wound closure: Excellent cosmetic results and patient comfort

1.

Anti-Xa-activiteit van therapeutisch nadroparine bij verminderde nierfunctie en behandeling conform richtlijn Nederlandse federatie voor nefrologie:vergelijking met standaarddosis...

2.

Anti-Xa-activiteit van therapeutisch nadroparine bij verminderde nierfunctie en behandeling conform richtlijn Nederlandse federatie voor nefrologie:vergelijking met standaarddosis...

3.

Anti-Xa-activiteit van therapeutisch nadroparine bij verminderde nierfunctie en behandeling conform richtlijn Nederlandse federatie voor nefrologie:vergelijking met standaarddosis...

4.

Anti-Xa-activiteit van therapeutisch nadroparine bij verminderde nierfunctie en behandeling conform richtlijn Nederlandse federatie voor nefrologie:vergelijking met standaarddosis...

5.

Anti-Xa-activiteit van therapeutisch nadroparine bij verminderde nierfunctie en behandeling conform richtlijn Nederlandse federatie voor nefrologie:vergelijking met standaarddosis...

6.

Anti-Xa-activiteit van therapeutisch nadroparine bij verminderde nierfunctie en behandeling conform richtlijn Nederlandse federatie voor nefrologie:vergelijking met standaarddosis...

7.

Anti-Xa-activiteit van therapeutisch nadroparine bij verminderde nierfunctie en behandeling conform richtlijn Nederlandse federatie voor nefrologie:vergelijking met standaarddosis...

8.

Anti-Xa-activiteit van therapeutisch nadroparine bij verminderde nierfunctie en behandeling conform richtlijn Nederlandse federatie voor nefrologie:vergelijking met standaarddosis...

9.

Anti-Xa-activiteit van therapeutisch nadroparine bij verminderde nierfunctie en behandeling conform richtlijn Nederlandse federatie voor nefrologie:vergelijking met standaarddosis...

1.

Change of initial oral antidiabetic therapy in type 2 diabetic patients

2.

Change of initial oral antidiabetic therapy in type 2 diabetic patients

3.

Change of initial oral antidiabetic therapy in type 2 diabetic patients

4.

Change of initial oral antidiabetic therapy in type 2 diabetic patients